SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950103-17-001127
Filing Date
2017-02-06
Accepted
2017-02-06 14:02:59
Documents
1
Group Members
BAXALTA GMBHSHIRE PLC

Document Format Files

Seq Description Document Type Size
1 FORM SC 13G/A dp71937_sc13ga-a3.htm SC 13G/A 97461
  Complete submission text file 0000950103-17-001127.txt   99211
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Subject) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87566 | Film No.: 17575021
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1200 LAKESIDE DRIVE BANNOCKBURN IL 60015
Business Address 1200 LAKESIDE DRIVE BANNOCKBURN IL 60015 224-940-2000
Baxalta Inc (Filed by) CIK: 0001620546 (see all company filings)

IRS No.: 471869689 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations